Oppenheimer Reiterates Outperform Rating on UroGen Pharma (URGN), 'reiterate URGN as a top pick'
Go back to Oppenheimer Reiterates Outperform Rating on UroGen Pharma (URGN), 'reiterate URGN as a top pick'| (NASDAQ: URGN) | Delayed: 47.85 -0.27 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.12 | 52 Week High | $ | |||
| Open | $47.68 | 52 Week Low | $ | |||
| Day High | $47.95 | P/E | N/A | |||
| Day Low | $46.62 | EPS | $ | |||
| Volume | 127,578 | |||||

